• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型 Abobotulinum-toxin A(Dysport)注射技术治疗眉间纹的疗效和并发症。

The efficacy and complications of a new technique of Abobotulinum-toxin A (Dysport) injection in patients with glabellar lines.

机构信息

Physiology Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.

Institute of Neuropharmacology, Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran.

出版信息

J Cosmet Dermatol. 2019 Feb;18(1):55-58. doi: 10.1111/jocd.12529. Epub 2018 Mar 23.

DOI:10.1111/jocd.12529
PMID:29569830
Abstract

BACKGROUND

Abobotulinum- toxin A is used extensively for the treatment of frown (glabellar) lines.

AIMS

The aim of this study was to evaluate the efficacy and complications of a new injection technique and to assess the amount of satisfaction in patients with the frown lines.

METHODS

This cross-sectional study was conducted in 104 patients with moderate-to-severe glabellar lines. In the new technique by reassessing the responsible anatomic muscles of wrinkles, we tried to modify the injection technique of Abobotulinum-toxin A to yield more favorable results. The range and severity of frown lines were assessed by a 4-score test and a photograph taken before and 2 weeks after the injection. Patients were followed up to 180 days after injection.

RESULTS

The response time of 87.5% of patients was within the first 48 hours and the remaining 12.5% showed the symptoms within the first week after injection. At 30 days after injection, the frown lines had disappeared in 88.5% of patients in static mode and 85.6% in mechanic mode. Maximum injection durability in the first 3, 4, and 6 months after injection was 82%, 52%, and 38%, respectively. The amount of complete satisfaction after 3 months was reported to be 86.5%.

CONCLUSIONS

This study indicated that the new injection technique of Abobotulinum-toxin A could be beneficial in the treatment of frown lines with more satisfactory results, especially in those patients who were not contented with the present conventional method.

摘要

背景

肉毒毒素 A 被广泛用于治疗皱眉(眉间)纹。

目的

本研究旨在评估一种新的注射技术的疗效和并发症,并评估患者对皱眉线的满意度。

方法

这是一项横断面研究,共纳入 104 例中重度眉间纹患者。在新的技术中,我们重新评估了皱纹的责任解剖肌,试图修改肉毒毒素 A 的注射技术,以获得更理想的效果。使用 4 分制测试和注射前后 2 周的照片评估皱眉线的范围和严重程度。患者在注射后 180 天内接受随访。

结果

87.5%的患者在 48 小时内出现反应,其余 12.5%的患者在注射后第一周内出现症状。在注射后 30 天,88.5%的患者在静态模式下和 85.6%的患者在机械模式下皱眉线消失。注射后 3、4 和 6 个月时的最大注射持续时间分别为 82%、52%和 38%。3 个月后完全满意的比例为 86.5%。

结论

本研究表明,肉毒毒素 A 的新注射技术可能对皱眉线的治疗有益,效果更令人满意,特别是对那些对现有常规方法不满意的患者。

相似文献

1
The efficacy and complications of a new technique of Abobotulinum-toxin A (Dysport) injection in patients with glabellar lines.一种新型 Abobotulinum-toxin A(Dysport)注射技术治疗眉间纹的疗效和并发症。
J Cosmet Dermatol. 2019 Feb;18(1):55-58. doi: 10.1111/jocd.12529. Epub 2018 Mar 23.
2
A Phase III Clinical Study of the Efficacy and Safety of Botulinum Toxin Type A (MASPORT) with DYSPORT for the Treatment of Glabellar Lines.A型肉毒毒素(MASPORT)与 DYSPORT 治疗眉间纹的疗效和安全性的 III 期临床研究。
Aesthetic Plast Surg. 2024 Feb;48(3):324-332. doi: 10.1007/s00266-023-03766-5. Epub 2024 Jan 17.
3
Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.阿替卡因肾上腺素用于治疗中国患者眉间纹的疗效和安全性:一项关键性、3 期、随机、双盲、开放性研究。
Aesthetic Plast Surg. 2023 Feb;47(1):351-364. doi: 10.1007/s00266-022-03164-3. Epub 2022 Dec 19.
4
Evaluation of the safety and efficacy of a biosimilar abobotulinum toxin type A in treating moderate-to-severe glabellar lines: A non-inferiority double blinded randomized controlled trial.一种阿替卡因肾上腺素注射液用于口腔颌面外科手术局部浸润麻醉的有效性和安全性的多中心、随机、阳性药物平行对照临床试验
J Cosmet Dermatol. 2022 Jun;21(6):2398-2406. doi: 10.1111/jocd.14939. Epub 2022 Apr 9.
5
Onset, longevity, and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines: a single-arm, prospective clinical study.衡力肉毒素治疗眉间竖纹的起效时间、持续时间和患者满意度:一项单臂前瞻性临床研究。
Clin Interv Aging. 2013;8:449-56. doi: 10.2147/CIA.S34854. Epub 2013 Apr 24.
6
Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.A型肉毒杆菌毒素(丽舒妥)3针和5针注射模式(30单位和50单位)用于治疗眉间纹和额中央区域皱纹的疗效及安全性。
Arch Dermatol. 2006 Mar;142(3):320-6. doi: 10.1001/archderm.142.3.320.
7
Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study.眉间肌内肉毒毒素剂量与疗效和安全性神经生理参数的相关性:一项双盲、安慰剂对照、随机研究。
Acta Derm Venereol. 2014 Jan;94(1):32-7. doi: 10.2340/00015555-1647.
8
The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines.注射用A型肉毒毒素治疗中重度眉间纹的疗效与安全性。
Plast Reconstr Surg. 2015 Mar;135(3):732-741. doi: 10.1097/PRS.0000000000001032.
9
Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.一项新的肉毒毒素 A 治疗眉间纹的随机、安慰剂对照研究:疗效和安全性。
Dermatol Surg. 2009 Dec;35(12):1893-901. doi: 10.1111/j.1524-4725.2009.01235.x.
10
Efficacy and safety of a novel botulinum toxin type A product for the treatment of moderate to severe glabellar lines: a randomized, double-blind, active-controlled multicenter study.一种新型肉毒毒素 A 产品治疗中度至重度眉间纹的疗效和安全性:一项随机、双盲、阳性对照、多中心研究。
Dermatol Surg. 2013 Jan;39(1 Pt 2):171-8. doi: 10.1111/dsu.12072.

引用本文的文献

1
Decades of Scientific Data and Global Media Reporting on Complications in Non-surgical Aesthetic Treatments for a Transparent Safety Profile: Kissing Snow White Awake.数十年科学数据及全球媒体对非手术美容治疗并发症的报道,以呈现透明的安全概况:唤醒白雪公主之吻。
Aesthetic Plast Surg. 2025 Jul 1. doi: 10.1007/s00266-025-05007-3.
2
Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.阿替卡因肾上腺素用于治疗中国患者眉间纹的疗效和安全性:一项关键性、3 期、随机、双盲、开放性研究。
Aesthetic Plast Surg. 2023 Feb;47(1):351-364. doi: 10.1007/s00266-022-03164-3. Epub 2022 Dec 19.
3
Neuromodulating the SMAS for Natural Dynamic Results.
通过神经调节SMAS实现自然动态效果。
Plast Reconstr Surg Glob Open. 2021 Aug 25;9(8):e3755. doi: 10.1097/GOX.0000000000003755. eCollection 2021 Aug.
4
Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Analysis of the APPEAL Study.患者对上半脸美学用途阿柏毒素A的满意度:系统文献综述及 APPEAL 研究分析
J Clin Aesthet Dermatol. 2021 Feb;14(2):E69-E88. Epub 2021 Feb 1.
5
The whole truth about botulinum toxin - a review.肉毒杆菌毒素的全部真相——一篇综述
Postepy Dermatol Alergol. 2020 Dec;37(6):853-861. doi: 10.5114/ada.2019.82795. Epub 2019 Feb 5.
6
Onset and Duration of AbobotulinumtoxinA for Aesthetic Use in the Upper face: A Systematic Literature Review.用于上脸美容的阿柏毒素A的起效时间和持续时间:一项系统文献综述
J Clin Aesthet Dermatol. 2020 Dec;13(12):E56-E83. Epub 2020 Dec 1.